61 research outputs found
Autologous chondrocyte implantation versus ACI using 3D-bioresorbable graft for the treatment of large full-thickness cartilage lesions of the knee
Background: In autologous chondrocyte implantation (ACI), the periosteum patch which is sutured over the cartilage defect has been identified as a major source of complications such as periosteal hypertrophy. In the present retrospective study, we compared midterm results of first-generation ACI with a periosteal patch to second generation ACI using a biodegradable collagen fleece (BioSeed-C) in 82 patients suffering from chronic posttraumatic and degenerative cartilage lesions of the knee. Methods: Clinical outcome was assessed in 42 patients of group 1 and in 40 patients of group 2 before implantation of the autologous chondrocytes and at a minimum follow-up of 2years using the ICRS score, the modified Cincinnati score and the Lysholm score. Results: Although patients treated with BioSeed-C had more previous surgical procedures on their respective knees, highly significant improvements (P<0.001) were assessed in both groups at comparable outcome levels: the ICRS score improved from grade D (poor) preoperatively to grade C (fair); the modified Cincinnati knee score from 3.26 to 6.4 (group 1) and 3.3 and 6.88 (group 2). Lysholm score improved from 33 to 70 points (group 1) and from 47 to 78 points (group 2), respectively. Revision surgery was due to symptomatic periosteal hypertrophy (n=4), graft failure (n=3), plica syndrome (n=2) synovectomy (n=1) (group 1); and graft failure (n=2), debridement (n=1), synovectomy (n=2) (group 2). Conclusion: These results suggest that BioSeed-C is an equally effective treatment option for focal degenerative chondral lesions of the knee in this challenging and complex patient profil
Effects of pre-farrowing sow vaccination against Mycoplasma hyopneumoniae on offspring colonisation and lung lesions
This study investigated Mycoplasma hyopneumoniae colonisation and lung lesions at slaughter in pigs from vaccinated (V) and non-vaccinated (NV) sows, in two herds (A and B). In each herd, two sow batches were V against M. hyopneumoniae with a commercial bacterin at six and three weeks before farrowing and two sow batches remained NV. From each sow batch, laryngeal swabs were collected from the litters of five primiparous sows at weaning and seven days post-weaning. All samples were tested for M. hyopneumoniae by nested PCR. In total, 488 piglets were sampled. At slaughter, the extent of Mycoplasma-like pneumonia lesions (lung lesion score (LLS)) was assessed. The colonisation rates with M. hyopneumoniae at weaning and seven days post-weaning were (V-A=14.2, NV-A=20.0 (P=0.225); V-B=0.9, NV-B=0.8 (P=0.948)) and (V-A=0.8, NV-A=7.0 (P=0.039); V-B=1.8, NV-B=2.5 (P=0.738)), respectively. The average LLS (in per cent) was V-A=15.5, NV-A=26.4 (P=0.021); V-B=9.7, NV-B=8.4 (P=0.541). In conclusion, in herd A, with a substantially higher level of piglet colonisation at weaning than herd B, offspring from V sows had a significantly lower colonisation rate seven days post-weaning and a significantly lower LLS at slaughter compared with the offspring of the NV sows. This implies that sow vaccination might be useful for control of M. hyopneumoniae infections, although significant results may not be achieved at all times (such as in herd B)
Autologous chondrocyte implantation versus ACI using 3D-bioresorbable graft for the treatment of large full-thickness cartilage lesions of the knee
BACKGROUND: In autologous chondrocyte implantation (ACI), the periosteum patch which is sutured over the cartilage defect has been identified as a major source of complications such as periosteal hypertrophy. In the present retrospective study, we compared midterm results of first-generation ACI with a periosteal patch to second generation ACI using a biodegradable collagen fleece (BioSeed-C) in 82 patients suffering from chronic posttraumatic and degenerative cartilage lesions of the knee. METHODS: Clinical outcome was assessed in 42 patients of group 1 and in 40 patients of group 2 before implantation of the autologous chondrocytes and at a minimum follow-up of 2 years using the ICRS score, the modified Cincinnati score and the Lysholm score. RESULTS: Although patients treated with BioSeed-C had more previous surgical procedures on their respective knees, highly significant improvements (P < 0.001) were assessed in both groups at comparable outcome levels: the ICRS score improved from grade D (poor) preoperatively to grade C (fair); the modified Cincinnati knee score from 3.26 to 6.4 (group 1) and 3.3 and 6.88 (group 2). Lysholm score improved from 33 to 70 points (group 1) and from 47 to 78 points (group 2), respectively. Revision surgery was due to symptomatic periosteal hypertrophy (n = 4), graft failure (n = 3), plica syndrome (n = 2) synovectomy (n = 1) (group 1); and graft failure (n = 2), debridement (n = 1), synovectomy (n = 2) (group 2). CONCLUSION: These results suggest that BioSeed-C is an equally effective treatment option for focal degenerative chondral lesions of the knee in this challenging and complex patient profile
Different hyaluronic acid morphology modulates primary articular chondrocyte behavior in hyaluronic acid-coated polycaprolactone scaffolds
Scaffolds for cartilage tissue engineering should
promote both adequate biomechanical environment and
chondrogenic stimulation. Hyaluronic acid (HA) has been
used in cartilage engineering for its chondrogenic and
chondroprotective properties, nevertheless its mechanical
properties are limited. Influence of HA microstructure in
chondrocyte response has not been addressed yet. In this
work, polycaprolactone (PCL) scaffolds were modified using
HA following two coating strategies: coating in one step
(PCL-HA1s) yields a gel-like phase within the scaffold,
whereas a two-step reaction (PCL-HA2s) yields a thin HA
layer coating internal surfaces of PCL structure. Chondrocytes
were seeded in the scaffolds and cultured in dedifferentiating
conditions up to 3 weeks and analyzed using a total DNA
assay and sulfated glycosaminoglycan (sGAG) determination
assay; cell morphology and extracellular matrix secretion
were assessed by electron microscopy as well as immunofluorescent imaging (collagen I, collagen II, aggrecan, CD44).
Cells proliferate in all samples and no cytotoxicity is observed.
PCL-HA1s shows higher sGAG production per cell than PCL
and PCL-HA2s at all times. Presence of hyaluronic acid promotes
qualitative expression of CD44 surface markers and
aggrecan (more visible in PCL-HA1s than PCL-HA2s), whereas
in dedifferentiating conditions, expression of CD44 and aggrecan
can hardly be detected in pure PCL scaffolds. Collagen
type II seems more prominent in PCL-HA2s; although PCLHA2s
shows markers for COL II, aggrecan and CD44, quantitative
ECM production is not improved with respect to PCL. It is
thus likely that CD44 activation is not sufficient for explaining
the better response in PCL-HA1s.Contract grant sponsor: Valencia Polytechnic University; contract grant number: PAID-06-10Contract grant sponsor: Spanish Ministry of Science; contract grant number: MAT2010-21611-C03-01Contract grant sponsors: CIBER-BBN; VI National R&D&i Plan 2008-2011; Iniciativa Ingenio 2010; Consolider Program; Instituto de Salud Carlos III; European Regional Development Fund; Valencian Generality; Conselleria de Sanidad (Generalitat Valenciana
Synovial chondromatosis of the hip with atypical MRI morphology and mistakable clinical symptoms — a case report
Osteogenic programming of human mesenchymal stem cells with highly efficient intracellular delivery of RUNX2
Mesenchymal stem cells (MSCs) are being exploited in regenerative medicine due to their tri-lineage differentiation and immunomodulation activity. Currently, there are two major challenges when directing the differentiation of MSCs for therapeutic applications. First, chemical and growth factor strategies to direct osteogenesis in vivo lack specificity for targeted delivery with desired effects. Second, MSC differentiation by gene therapy is difficult as transfection with existing approaches is clinically impractical (viral transfection) or have low efficacy (lipid-mediated transfection). These challenges can be avoided by directly delivering nonvirally derived recombinant protein transcription factors with the glycosaminoglycan-binding enhanced transduction (GET) delivery system (P21 and 8R peptides). We used the osteogenic master regulator, RUNX2 as a programming factor due to its stage-specific role in osteochondral differentiation pathways. Herein, we engineered GET-fusion proteins and compared sequential osteogenic changes in MSCs, induced by exposure to GET fusion proteins or conventional stimulation methods (dexamethasone and Bone morphogenetic protein 2). By assessing loss of stem cell-surface markers, upregulation of osteogenic genes and matrix mineralization, we demonstrate that GET-RUNX2 efficiently transduces MSCs and triggers osteogenesis by enhancing target gene expression directly. The high transduction efficiency of GET system holds great promise for stem cell therapies by allowing reproducible transcriptional control in stem cells, potentially bypassing problems observed with high-concentration growth-factor or pleiotropic steroid therapies
An alginate hydrogel matrix for the localised delivery of a fibroblast/keratinocyte co-culture
The subchondral bone in articular cartilage repair: current problems in the surgical management
As the understanding of interactions between articular cartilage and subchondral bone continues to evolve, increased attention is being directed at treatment options for the entire osteochondral unit, rather than focusing on the articular surface only. It is becoming apparent that without support from an intact subchondral bed, any treatment of the surface chondral lesion is likely to fail. This article reviews issues affecting the entire osteochondral unit, such as subchondral changes after marrow-stimulation techniques and meniscectomy or large osteochondral defects created by prosthetic resurfacing techniques. Also discussed are surgical techniques designed to address these issues, including the use of osteochondral allografts, autologous bone grafting, next generation cell-based implants, as well as strategies after failed subchondral repair and problems specific to the ankle joint. Lastly, since this area remains in constant evolution, the requirements for prospective studies needed to evaluate these emerging technologies will be reviewed
Perceptions Of International Orientation
Using qualitative methodology, the researcher analyzed the perspectives of students attending a mandatory Office of International Students and Scholars, sponsored orientation. One week after classes started, four international students and one observer were interviewed on their perceptions regarding the orientation. Themes such as cultural adjustment, understanding professors, prejudice and discrimination, academic advising, and structured entry were presented
- …